Intrauterine Contraceptive Devices (IUCDs) Market Research Report Information By Type (Hormonal Intrauterine Device, Copper Intrauterine Device) and By End-User (Hospitals, Gynecology Clinics, Community Health Care Centers, Others)-Forecast to 2032

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE

6.1. Overview

Hormonal Intrauterine Device

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2. Copper Intrauterine Device

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER

7.1. Overview

7.2. Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Gynecology Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Community Health Care Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY REGION

8.1. Overview

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

9. COMPANY LANDSCAPE

9.1.1. Overview

9.1.2. Competitive Analysis

10. COMPANY PROFILES

10.1. Bayer AG

10.1.1. Company Overview

10.1.2. Product Type Overview

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. EUROGINE, S.L.

10.2.1. Company Overview

10.2.2. Product Type Overview

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. The Cooper Companies, Inc.

10.3.1. Company Overview

10.3.2. Product Type Overview

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Pfizer

10.4.1. Company Overview

10.4.2. Product Type Overview

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. HLL Lifecare Limited

10.5.1. Company Overview

10.5.2. Product Type Overview

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. OCON Healthcare

10.6.1. Company Overview

10.6.2. Product Type Overview

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. SMB Corporation

10.7.1. Company Overview

10.7.2. Product Type Overview

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Egemen International

10.8.1. Company Overview

10.8.2. Product Type Overview

10.8.3. Financial Overview

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Meril Life Sciences Pvt. Ltd.

10.9.1. Company Overview

10.9.2. Product Type Overview

10.9.3. Financial Overview

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Mona Lisa N.V.

10.10.1. Company Overview

10.10.2. Product Type Overview

10.10.3. Financial Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Prosan International B.V.

10.11.1. Company Overview

10.11.2. Product Type Overview

10.11.3. Financial Overview

10.11.4. Key Developments

10.11.5. SWOT Analysis

10.11.6. Key Strategies

10.12. Pregna International Limited

10.12.1. Company Overview

10.12.2. Product Type Overview

10.12.3. Financial Overview

10.12.4. Key Developments

10.12.5. SWOT Analysis

10.12.6. Key Strategies

10.13. Others

11. APPENDIX

11.1. References

11.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 6 NORTH AMERICA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 8 US: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 9 US: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 10 CANADA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 11 CANADA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 12 LATIN AMERICA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 13 LATIN AMERICA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 14 EUROPE: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 15 EUROPE: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 WESTERN EUROPE: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 17 WESTERN EUROPE: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 18 EASTERN EUROPE: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 19 EASTERN EUROPE: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET, BY END USER, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET

FIGURE 4 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE, BY END USER, 2020 (%)

FIGURE 6 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE BY REGION, 2020 (%)

FIGURE 7 NORTH AMERICA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 8 EUROPE: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE, BY REGION, 2020 (%)

FIGURE 9 WESTERN EUROPE: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 ASIA-PACIFIC: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 MIDDLE EAST & AFRICA: INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES (IUCDS) MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 13 BAYER AG: KEY FINANCIALS

FIGURE 14 BAYER AG: SEGMENTAL REVENUE

FIGURE 15 BAYER AG: REGIONAL REVENUE

FIGURE 16 EUROGINE, S.L.: KEY FINANCIALS

FIGURE 17 EUROGINE, S.L.: SEGMENTAL REVENUE

FIGURE 18 EUROGINE, S.L.: REGIONAL REVENUE

FIGURE 19 THE COOPER COMPANIES, INC.: KEY FINANCIALS

FIGURE 20 THE COOPER COMPANIES, INC.: SEGMENTAL REVENUE

FIGURE 21 THE COOPER COMPANIES, INC.: REGIONAL REVENUE

FIGURE 22 PFIZER: KEY FINANCIALS

FIGURE 23 PFIZER: SEGMENTAL REVENUE

FIGURE 24 PFIZER: REGIONAL REVENUE

FIGURE 25 HLL LIFECARE LIMITED: KEY FINANCIALS

FIGURE 26 HLL LIFECARE LIMITED: SEGMENTAL REVENUE

FIGURE 27 HLL LIFECARE LIMITED: REGIONAL REVENUE

FIGURE 28 OCON HEALTHCARE: KEY FINANCIALS

FIGURE 29 OCON HEALTHCARE: SEGMENTAL REVENUE

FIGURE 30 OCON HEALTHCARE: REGIONAL REVENUE

FIGURE 31 SMB CORPORATION: KEY FINANCIALS

FIGURE 32 SMB CORPORATION: SEGMENTAL REVENUE

FIGURE 33 SMB CORPORATION: REGIONAL REVENUE

FIGURE 34 EGEMEN INTERNATIONAL: KEY FINANCIALS

FIGURE 35 EGEMEN INTERNATIONAL: SEGMENTAL REVENUE

FIGURE 36 EGEMEN INTERNATIONAL: REGIONAL REVENUE

FIGURE 37 MERIL LIFE SCIENCES PVT. LTD.: KEY FINANCIALS

FIGURE 38 MERIL LIFE SCIENCES PVT. LTD.: SEGMENTAL REVENUE

FIGURE 39 MERIL LIFE SCIENCES PVT. LTD.: REGIONAL REVENUE

FIGURE 40 MONA LISA N.V.: KEY FINANCIALS

FIGURE 41 MONA LISA N.V.: SEGMENTAL REVENUE

FIGURE 42 MONA LISA N.V.: REGIONAL REVENUE

FIGURE 43 PROSAN INTERNATIONAL B.V.: KEY FINANCIALS

FIGURE 44 PROSAN INTERNATIONAL B.V.: SEGMENTAL REVENUE

FIGURE 45 PROSAN INTERNATIONAL B.V.: REGIONAL REVENUE

FIGURE 46 PREGNA INTERNATIONAL LIMITED: KEY FINANCIALS

FIGURE 47 PREGNA INTERNATIONAL LIMITED: SEGMENTAL REVENUE

FIGURE 48 PREGNA INTERNATIONAL LIMITED: REGIONAL REVENUE